tenofovir has been researched along with Proteinuria in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (20.37) | 29.6817 |
2010's | 37 (68.52) | 24.3611 |
2020's | 6 (11.11) | 2.80 |
Authors | Studies |
---|---|
Drak, D; Gowers, A; Gracey, DM; Lin, J | 1 |
Boesecke, C; Piduhn, H; Rockstroh, JK; Schlabe, S; Schwarze-Zander, C; Stoffel-Wagner, B; Strassburg, CP; Wasmuth, JC | 1 |
Bogner, JR; Hilge, R; Schrader, SY; Seybold, U; Zeder, AJ | 1 |
Byakika-Kibwika, P; Kalyesubula, R; Nyende, L; Sekasanvu, E | 1 |
Bwakura-Dangarembizi, MF; Maponga, CC; Mashingaidze-Mano, R; Monera-Penduka, TG; Morse, GD; Mtisi, TJ; Mudzviti, T; Mujuru, HA | 1 |
Bloch, M; Gracey, DM; Heron, JE; Saunders, J; Vanguru, V | 1 |
Hadigan, CM; Hazra, R; Jones, SE; Kopp, JB; Mattingly, AS; Purdy, JB; Reynolds, JC; Unsal, AB | 1 |
Atzori, C; Clementi, EGI; Falvella, FS; Galli, M; Giacomelli, A; Meraviglia, P; Oreni, ML; Rusconi, S; Salvaggio, SE | 1 |
Gallagher, A; Gracey, DM; Quan, D | 1 |
Anugulruengkitt, S; Bunupuradah, T; Chanakul, A; Jantarabenjakul, W; Phupitakphol, T; Prasitsuebsai, W; Puthanakit, T; Ruxrungtham, K; Sopa, B; Sophonphan, J | 1 |
Chen, M; Chow, EP; Fairley, CK; Medland, NA; Read, TR; Walker, RG | 1 |
Appiah, LT; Beloukas, A; Chadwick, D; Geretti, AM; Phillips, RO; Post, F; Ruggiero, A; Sarfo, FS; Smith, C; Stockdale, AJ; Villa, G | 1 |
Bennett, M; Coca, SG; Defechereux, P; Gandhi, M; Glidden, DV; Grant, RM; Jotwani, V; Liu, A; Mehrotra, M; Parikh, CR; Scherzer, R; Shlipak, MG | 1 |
Althoff, KN; Brown, TT; Estrella, MM; Gonciulea, A; Kingsley, LA; Lake, JE; Palella, FJ; Sellmeyer, DE; Wang, R | 1 |
Bąkowska, E; Firląg-Burkacka, E; Horban, A; Kowalska, JD; Matłosz, B; Vassilenko, A | 1 |
Cao, Y; Cui, Q; Han, Y; Li, T; Li, Y; Song, X; Xie, J; Zhang, L; Zhu, T | 1 |
Badiou, S; Chatron, M; Cournil, A; Cristol, JP; Guiller, E; Peyriere, H; Psomas, C; Reynes, J | 1 |
Abraham, P; Isaac, B; Ramamoorthy, H | 1 |
Brar, I; Callebaut, C; Elion, R; Fordyce, MW; Martin, H; McCallister, S; Ortiz, R; Post, F; Sax, PE; Wang, H; Zolopa, A | 1 |
Andrade-Fuentes, K; Gaytan-Martínez, J; López-De León, JI; Manjarrez-Téllez, B; Mata-Marín, JA; Ramírez, JL | 1 |
Daar, ES; Gupta, SK; Ha, B; Kitch, D; McComsey, GA; Melbourne, K; Sax, PE; Tierney, C; Wyatt, CM | 1 |
Carta, M; D'Angelo, A; Frassetti, N; Innico, G; Lai, C; Lai, S; Mangiulli, M; Mariotti, A; Russo, GE; Testorio, M | 1 |
Canetta, PA; Herlitz, L; Hirsch, JS; Mohan, S; Sise, ME | 1 |
Badiou, S; Casanova, ML; Cournil, A; Cristol, JP; Peyriere, H; Reynes, J | 1 |
Antonello, IC; Antonello, VS; Herrmann, S; Tovo, CV | 1 |
Abram, ME; Arribas, JR; Avihingsanon, A; Benson, P; Bloch, M; Cheng, A; Chetchotisakd, P; Crofoot, G; Custodio, JM; Fordyce, MW; Gathe, J; Gupta, SK; Lichtenstein, K; McCallister, S; Post, FA; Pozniak, A; Ramgopal, M; SenGupta, D; Wei, X | 1 |
Bedu-Addo, G; Chadwick, DR; Kirk, ES; Owusu, AL; Owusu, D; Parris, V; Phillips, R; Sarfo, FS | 1 |
Arribas, JR; Brinson, C; Brunetta, J; Callebaut, C; Cheng, A; Cheret, A; Clarke, A; Clumeck, N; Das, M; Fordyce, M; Mussini, C; Oka, S; Rashbaum, B; Sax, PE; Stephens, J; Tashima, K; Tebas, P; Wohl, D; Zhong, L | 1 |
Amer, H; Berg, ML; Cummins, NW; Marcelin, JR; Rizza, SA; Tan, EM | 1 |
Jones, R; Levy, JB; Milburn, J | 1 |
Bogner, JR; Hilge, R; Schrader, S; Seybold, U; Zeder, AJ | 1 |
Chen, SS; Cheng, AK; DeJesus, E; Enejosa, JV; Gallant, JE; Pozniak, AL; Winston, JA | 1 |
Barril Cuadrado, G; de Los Santos Gil, I | 1 |
Connolly, JO; Copas, A; Edwards, SG; Hall, AM; Johnson, MA; Madge, S; Nair, D; Williams, IG; Woodward, CL | 1 |
Chetty, K; Connolly, JO; Edwards, SG; Hall, AM; Lapsley, M; O'Farrell, S; Unwin, RJ; Williams, IG | 1 |
Agarwala, R; Cheng, JT; Herlitz, LC; Mohan, S | 1 |
D'Agati, VD; Herlitz, LC; Markowitz, GS; Mohan, S; Radhakrishnan, J; Stokes, MB | 1 |
Figueras, C; Fortuny, C; Garcia, L; Martín-Nalda, A; Melendo, S; Mellado, MJ; Navarro, ML; Noguera-Julian, A; Soler-Palacín, P; Uriona, S | 1 |
Perazella, MA | 1 |
Agarwal, R; Dubé, MP; Gupta, SK; Mather, KJ; Shen, C | 1 |
Ando, M; Nitta, K; Tsuchiya, K | 1 |
Choi, AI; Deeks, SG; Estrella, M; Grunfeld, C; Li, Y; Scherzer, R; Shlipak, MG | 1 |
Das, P; Ford, M; Holt, S; Kingdon, E; Vivek, V | 1 |
Bartlett, H; Gibson, A; Kelly, MD; Patten, J; Rowling, D | 1 |
Borderi, M; Calza, L; Colangeli, V; Di Bari, MA; Magistrelli, E; Manfredi, R; Salvadori, C; Trapani, F; Viale, P | 1 |
Chernoff, MC; Hazra, R; Kopp, JB; Mofenson, LM; Patel, K; Purswani, M; Scott, GB; Seage, GR; Siberry, GK; Van Dyke, RB | 1 |
Benson, P; Bredeek, UF; Brinson, C; Campo, R; Dau, L; DeJesus, E; Flaherty, J; Fralich, T; Guyer, B; Henry, K; Khanlou, H; Logue, K; Piontkowsky, D; Wang, H; White, K | 1 |
Bourgarit, A; Droz, D; Furco, A; Karras, A; Lafaurie, M; Legendre, C; Martinez, F; Molina, JM; Sereni, D | 1 |
Daniel, N; de Boever, CM; Leray, H; Mauboussin, JM; Moachon, L; Peyrière, H; Reynes, J; Rouanet, I; Salmon-Céron, D; Vincent, D | 1 |
Bower, M; Gazzard, B; Jones, R; Mandalia, S; Moyle, G; Nelson, M; Stebbing, J | 1 |
Berger, F; Mauss, S; Schmutz, G | 1 |
Antoniou, T; Chirhin, S; Gough, K; Govan, V; Loutfy, M; Raboud, J; Rachlis, A; Yoong, D | 1 |
Fine, DM | 1 |
Blanche, S; Dechaux, M; Jullien, V; Papaleo, A; Salomon, R; Veber, F; Warszawski, J | 1 |
4 review(s) available for tenofovir and Proteinuria
Article | Year |
---|---|
Renal effects of novel antiretroviral drugs.
Topics: Adenine; Alanine; Anti-HIV Agents; Atazanavir Sulfate; Cobicistat; Creatinine; Disease Progression; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Oxazines; Piperazines; Proteinuria; Pyridones; Quinolones; Raltegravir Potassium; Renal Insufficiency, Chronic; Tenofovir | 2017 |
[Management of renal toxicity in HIV-positive patients. What to measure, how to measure it and how frequently].
Topics: Adenine; Algorithms; Anti-HIV Agents; beta 2-Microglobulin; Clinical Trials as Topic; Cohort Studies; Creatinine; Drug Monitoring; Female; HIV Infections; Humans; Hypophosphatemia; Incidence; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Organophosphonates; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors | 2008 |
How to manage HIV-infected patients with chronic kidney disease in the HAART era.
Topics: Adenine; Albuminuria; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black People; Cystatin C; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Failure, Chronic; Organophosphonates; Prevalence; Proteinuria; Risk Factors; Tenofovir; Viral Load | 2012 |
Editorial comment: tenofovir nephrotoxicity--vigilance required.
Topics: Adenine; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Hypokalemia; Hypophosphatemia; Organophosphonates; Proteinuria; Renal Insufficiency; Reverse Transcriptase Inhibitors; Tenofovir | 2005 |
9 trial(s) available for tenofovir and Proteinuria
Article | Year |
---|---|
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
Topics: Adult; Albuminuria; Alpha-Globulins; Anti-HIV Agents; Biomarkers; Cross-Sectional Studies; Emtricitabine; Female; Glomerular Filtration Rate; HIV; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Pre-Exposure Prophylaxis; Proteinuria; Tenofovir; Transgender Persons; Urine; Young Adult | 2018 |
Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.
Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Organophosphonates; Prospective Studies; Protease Inhibitors; Proteinuria; Ritonavir; Statistics, Nonparametric; Tenofovir | 2013 |
Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.
Topics: Absorptiometry, Photon; Adenine; Administration, Oral; Adult; Alanine; Bone Density; CD4 Lymphocyte Count; Cholesterol; Creatinine; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Prodrugs; Proteinuria; RNA, Viral; Tenofovir; United States | 2014 |
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.
Topics: Adenine; Adult; Albuminuria; Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Lamivudine; Linear Models; Male; Organophosphonates; Proteinuria; Tenofovir | 2014 |
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
Topics: Adult; Albuminuria; Bone Density; Cobicistat; Drug Substitution; Drug Therapy, Combination; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Quinolones; Renal Insufficiency; Tenofovir | 2016 |
Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Causality; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Ghana; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Prevalence; Proteinuria; Risk Assessment; Tenofovir | 2015 |
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.
Topics: Adenine; Alanine; Albuminuria; Anti-HIV Agents; Bone Density; CD4 Lymphocyte Count; Cobicistat; Double-Blind Method; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Proteinuria; Quinolones; RNA, Viral; Tenofovir | 2016 |
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Phosphorus; Proteinuria; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Young Adult; Zidovudine | 2008 |
SWIFT: prospective 48-week study to evaluate efficacy and safety of switching to emtricitabine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen.
Topics: Adenine; Adult; Aged; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Protease Inhibitors; Proteinuria; Risk; Tenofovir | 2013 |
41 other study(ies) available for tenofovir and Proteinuria
Article | Year |
---|---|
Fanconi syndrome in a patient receiving pre-exposure prophylaxis for HIV infection: case report.
Topics: Anti-HIV Agents; Emtricitabine; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Pre-Exposure Prophylaxis; Proteinuria; Renal Insufficiency; Tenofovir | 2022 |
Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
Topics: Age Factors; Alanine; Albuminuria; Cholesterol, LDL; Drug Substitution; Female; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Retrospective Studies; Tenofovir; Time Factors | 2020 |
Medium-grade proteinuria is a risk factor for incident markers of chronic kidney disease.
Topics: Adult; Age Factors; Anti-HIV Agents; Biomarkers; Disease Progression; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Practice Guidelines as Topic; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Tenofovir | 2020 |
Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glycosuria; HIV Infections; Humans; Hypercalcemia; Hyperkalemia; Hyperphosphatemia; Hypocalcemia; Hypokalemia; Hypophosphatemia; Lamivudine; Male; Middle Aged; Prevalence; Proteinuria; Renal Insufficiency; Tenofovir; Uganda | 2020 |
Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
Topics: Adolescent; Anti-HIV Agents; Child; Cross-Sectional Studies; Fanconi Syndrome; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Tertiary Care Centers; Zimbabwe | 2020 |
Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report.
Topics: Acute Disease; Alanine; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemotherapy-Induced Febrile Neutropenia; Deprescriptions; Drug Interactions; Fanconi Syndrome; Gentamicins; Glycosuria; HIV Infections; Hodgkin Disease; Humans; Hypokalemia; Hypophosphatemia; Male; Middle Aged; Proteinuria; Tenofovir | 2020 |
Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life.
Topics: Absorptiometry, Photon; Acid-Base Equilibrium; Adult; Age of Onset; Albuminuria; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Case-Control Studies; Creatinine; Cross-Sectional Studies; Didanosine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Function Tests; Longitudinal Studies; Male; Osteocalcin; Prospective Studies; Proteinuria; Renal Insufficiency; Risk Factors; Stavudine; Tenofovir; Time Factors; Young Adult | 2017 |
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
Topics: Adult; Alleles; Anti-HIV Agents; Cohort Studies; Female; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Polymorphism, Single Nucleotide; Proteinuria; Tenofovir | 2017 |
Improvement in renal function and resolution of proteinuria in an HIV-infected patient switched from tenofovir disoproxil fumarate to tenofovir alafenamide.
Topics: Adenine; Alanine; Antiviral Agents; Drug Substitution; Female; HIV Infections; Humans; Kidney Diseases; Middle Aged; Proteinuria; Tenofovir | 2017 |
Prevalence of Persistent Renal Dysfunction in Perinatally HIV-infected Thai Adolescents.
Topics: Adolescent; Anti-HIV Agents; Child; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Prevalence; Proteinuria; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tenofovir; Thailand | 2018 |
Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate.
Topics: Adult; Anti-HIV Agents; Australia; Creatinine; Fanconi Syndrome; HIV Infections; Humans; Incidence; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tenofovir | 2018 |
Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; Female; Ghana; Glomerular Filtration Rate; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Tenofovir; Time Factors | 2018 |
Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection.
Topics: Adult; Anti-HIV Agents; Fractures, Bone; HIV Infections; Homosexuality, Male; Humans; Male; Middle Aged; Prevalence; Proportional Hazards Models; Prospective Studies; Proteinuria; Risk Factors; Tenofovir | 2019 |
Discontinuation of tenofovir due to nephrotoxicity: insight into 12 years of clinical practice
Topics: Adult; Anti-Retroviral Agents; Female; Glomerular Filtration Rate; Hematuria; HIV Infections; Humans; Kidney Diseases; Male; Middle Aged; Proteinuria; Retrospective Studies; Tenofovir | 2019 |
Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Cross-Sectional Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Organophosphonates; Proteinuria; Regression Analysis; Renal Insufficiency, Chronic; Risk Factors; Tenofovir | 2013 |
Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
Topics: Adenine; Animals; Anti-HIV Agents; Electron Transport Chain Complex Proteins; Fanconi Syndrome; Kidney Tubules, Proximal; Male; Mitochondria; Mitochondrial Swelling; Organophosphonates; Proteinuria; Rats, Wistar; Tenofovir | 2014 |
Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dideoxynucleosides; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Tubules, Proximal; Longitudinal Studies; Male; Mexico; Middle Aged; Organophosphonates; Prospective Studies; Protease Inhibitors; Proteinuria; Tenofovir | 2015 |
Tenofovir-Related Nephropathies in HIV-Infected Patients.
Topics: Acute Kidney Injury; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Function Tests; Male; Middle Aged; Proteinuria; Tenofovir | 2015 |
Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
Topics: Anti-HIV Agents; Biomarkers; Biopsy; Female; HIV Infections; Humans; Kidney; Male; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Proteinuria; Retrospective Studies; Tenofovir | 2015 |
Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria.
Topics: Adult; Aged; Anti-HIV Agents; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Kidney Tubules; Longitudinal Studies; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Proteinuria; Tenofovir; Time Factors; Viral Load | 2015 |
Proteinuria is common among HIV patients: what are we missing?
Topics: Adult; Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Middle Aged; Poisson Distribution; Prevalence; Proteinuria; Risk Factors; Tenofovir; Young Adult | 2015 |
Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?
Topics: Adult; Anti-HIV Agents; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Osmolar Concentration; Proteinuria; Retrospective Studies; Tenofovir | 2016 |
Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Anti-HIV Agents; Cross-Sectional Studies; Female; Germany; HIV; HIV Infections; Humans; Male; Middle Aged; Prevalence; Proteinuria; Risk Factors; Tenofovir; Young Adult | 2016 |
Tenofovir-associated renal and bone toxicity.
Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Glycosuria; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Mass Screening; Middle Aged; Organophosphonates; Osteomalacia; Proteinuria; Radionuclide Imaging; Tenofovir | 2009 |
Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
Topics: Acetylglucosaminidase; Adenine; Adult; Aged; Albuminuria; Anti-Retroviral Agents; Creatinine; Cross-Sectional Studies; Disease Progression; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Phosphates; Proteinuria; Retinol-Binding Proteins; Risk Factors; Sensitivity and Specificity; Tenofovir | 2009 |
The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity.
Topics: Adenine; Adult; Anti-HIV Agents; Biopsy; Disease Progression; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Organophosphonates; Proteinuria; Tenofovir | 2010 |
Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Biopsy; Drug Administration Schedule; Female; Glycosuria; HIV Infections; HIV-1; Humans; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Male; Microscopy, Electron; Middle Aged; Mitochondria; New York City; Organophosphonates; Proteinuria; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Tenofovir; Time Factors | 2010 |
Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens.
Topics: Adenine; Adolescent; Antiretroviral Therapy, Highly Active; Child; Female; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Organophosphonates; Prospective Studies; Proteinuria; Spain; Tenofovir | 2011 |
Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Topics: Acute Kidney Injury; Adenine; Animals; Anti-HIV Agents; Drug Administration Schedule; Glycosuria; HIV Infections; HIV-1; Humans; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Mitochondria; Organophosphonates; Proteinuria; Renal Dialysis; Renal Insufficiency; Tenofovir; Time Factors | 2010 |
Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.
Topics: Adenine; Adult; Albuminuria; Alkynes; Anti-HIV Agents; Benzoxazines; Brachial Artery; Chi-Square Distribution; Creatinine; Cyclopropanes; Dideoxynucleosides; Endothelium, Vascular; Female; Glomerular Filtration Rate; HIV Infections; Humans; Linear Models; Male; Middle Aged; Organophosphonates; Proteinuria; Tenofovir; Ultrasonography; Vasodilation | 2011 |
Association of tenofovir exposure with kidney disease risk in HIV infection.
Topics: Adenine; Adult; Anti-HIV Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organophosphonates; Proteinuria; Risk Factors; Tenofovir; Time Factors; Treatment Outcome | 2012 |
Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir.
Topics: Adenine; Glomerulonephritis, Membranous; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult | 2011 |
Tenofovir-associated proteinuria.
Topics: Adenine; Anti-HIV Agents; Creatine; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Proteinuria; Renal Insufficiency, Chronic; Tenofovir | 2013 |
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.
Topics: Adenine; Adult; Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; Glomerular Filtration Rate; Glycosuria; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Lopinavir; Male; Middle Aged; Oligopeptides; Organophosphonates; Proteinuria; Pyridines; Retrospective Studies; Ritonavir; Tenofovir | 2013 |
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.
Topics: Adenine; Adolescent; Anti-HIV Agents; Black or African American; Child; Cohort Studies; Female; Hispanic or Latino; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Multivariate Analysis; Odds Ratio; Organophosphonates; Prevalence; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Statistics, Nonparametric; Tenofovir; United States | 2013 |
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
Topics: Acidosis; Adenine; Adult; Anti-HIV Agents; Creatinine; Diabetes Insipidus, Nephrogenic; Drug Monitoring; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Proteinuria; Renal Insufficiency; Tenofovir | 2003 |
Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Drug Therapy, Combination; Female; Glycosuria; Humans; Hypophosphatemia; Kidney Tubules; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Proteinuria; Tenofovir; Treatment Outcome | 2004 |
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study.
Topics: Adenine; Albuminuria; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Creatinine; Follow-Up Studies; HIV Infections; Humans; Organophosphonates; Proteinuria; Renal Insufficiency; Tenofovir | 2004 |
Antiretroviral therapy with tenofovir is associated with mild renal dysfunction.
Topics: Adenine; Anti-HIV Agents; Creatinine; Cross-Sectional Studies; Cystatin C; Cystatins; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Diseases; Organophosphonates; Proteinuria; Tenofovir | 2005 |
Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.
Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Female; HIV Infections; Humans; Hypophosphatemia; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Proteinuria; Retrospective Studies; Risk Factors; Tenofovir; Urinalysis | 2005 |
Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir.
Topics: Adenine; Adolescent; Adult; beta 2-Microglobulin; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Organophosphonates; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Urine | 2007 |